top of page

Rewriting Immune Medicine with a Truly Revolutionary Platform

OmniAntigen™ powers rapid, personalized immune therapies for cancer —and future diseases.

Novastra Therapeutics is a Boston-founded, clinical-stage biotech unlocking full-spectrum immunity with our proprietary OmniAntigen™ platform. In less than three hours, we transform patient- or pathogen-derived cells into potent micro-vaccines, delivering same-day, tailor-made therapies while keeping treatment simple, swift, and patient-centred.

About Novastra Therapeutics

Waiting Room

We engineer single-cell encapsulation solutions that preserve every antigen and supply a built-in immune trigger. Our first programme, OAP-1, is already in Phase I trials for solid tumours—demonstrating the speed and power of our platform. Next, we are extending OmniAntigen™ to whole-virus and cell-based vaccines that address emerging infectious and immune-mediated diseases.

Nurse with Young Patient

Our Mission

To make rapid, personalised immunotherapy a global reality—delivering hours-not-weeks solutions that improve outcomes and lighten the treatment burden.

Our Approach

Personalized Vaccines

Each dose is uniquely matched to the patient or pathogen.

Clinical Trials

OAP-1 is in Phase I, proving real-world feasibility.

Platform Versatility

Same technology cloaks tumour cells, viruses, or other antigen sources.

Global Integration

Boston-anchored science with worldwide development partners.

Patient Focus

Same-day turnaround minimises delays and hospital visits.

Execution Speed

Closed-system manufacturing compresses production to < 3 hours.

Advantages

Same-Day Manufacturing

Full-Spectrum Antigen Coverage

Built-In Immune Activation

First-in-Class Clinical Proof

Scalable Closed Process

Multi-Disease Potential

By the Numbers about OAP-1

*Phase I initiated Q1 2025

Young Nurse

Patient Stories*

*Individual results vary; OAP-1 currently investigational.

“Novastra Therapeutics has given me hope and a chance to fight cancer on my terms. Their personalized vaccine approach has made a significant impact on my treatment journey.”
“I am grateful to Novastra Therapeutics for their dedication to developing innovative cancer therapies. Their commitment to personalized care has truly made a difference in my life.”
“The team at Novastra Therapeutics goes above and beyond to ensure that patients like me receive the best possible care. Their compassionate approach has been a source of strength throughout my cancer treatment.”

Contact Us

Father and Son
bottom of page